DB Mark

508 total citations
15 papers, 396 citations indexed

About

DB Mark is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, DB Mark has authored 15 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in DB Mark's work include Cardiac, Anesthesia and Surgical Outcomes (6 papers), Coronary Interventions and Diagnostics (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). DB Mark is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (6 papers), Coronary Interventions and Diagnostics (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). DB Mark collaborates with scholars based in United States and Canada. DB Mark's co-authors include Pryor Db, Harrell Fe, KL Lee, RM Califf, Muhlbaier Lh, Rankin Js, Oldham Hn, Mark A. Hlatky, Smith Lr and Jones Rh and has published in prestigious journals such as Circulation, Value in Health and The Journal of invasive cardiology.

In The Last Decade

DB Mark

14 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DB Mark United States	9	317	192	124	28	24	15	396
Pryor Db United States	9	511 1.6×	322 1.7×	192 1.5×	31 1.1×	26 1.1×	14	606
Pablo Ancillo Spain	7	314 1.0×	108 0.6×	109 0.9×	15 0.5×	23 1.0×	12	376
M. G. Franzosi Italy	7	369 1.2×	115 0.6×	186 1.5×	25 0.9×	25 1.0×	11	469
John T. Rivers Australia	8	294 0.9×	107 0.6×	172 1.4×	38 1.4×	9 0.4×	14	390
Eugene Braunwald United States	8	306 1.0×	144 0.8×	130 1.0×	17 0.6×	12 0.5×	9	397
José L. López-Sendón Spain	6	355 1.1×	151 0.8×	141 1.1×	16 0.6×	27 1.1×	12	395
Craig E. Monsen United States	9	185 0.6×	127 0.7×	93 0.8×	19 0.7×	11 0.5×	31	301
S Moulopoulos New Zealand	4	339 1.1×	108 0.6×	117 0.9×	8 0.3×	16 0.7×	8	406
T. Robertson United States	5	267 0.8×	190 1.0×	119 1.0×	25 0.9×	8 0.3×	8	403
Elena Corrada Italy	12	223 0.7×	121 0.6×	82 0.7×	55 2.0×	14 0.6×	41	340

Countries citing papers authored by DB Mark

Since Specialization

Citations

This map shows the geographic impact of DB Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DB Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DB Mark more than expected).

Fields of papers citing papers by DB Mark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DB Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DB Mark. The network helps show where DB Mark may publish in the future.

Co-authorship network of co-authors of DB Mark

This figure shows the co-authorship network connecting the top 25 collaborators of DB Mark. A scholar is included among the top collaborators of DB Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DB Mark. DB Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Janzon, Magnus, Martin Henriksson, L. Scott Levin, et al.. (2010). Health Economics in the PLATelet Inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns. 1 indexed citations

Mark, DB, et al.. (2009). PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL. Value in Health. 12(3). A152–A152.

Kaul, Padma, et al.. (2004). Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.. PubMed. 20(8). 760–6. 3 indexed citations

Chang, WC, Yue Fu, M.P. Gupta, et al.. (2000). Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.. PubMed. 16(10). 1231–9. 8 indexed citations

Lee, KL, et al.. (1999). Long Term Results from the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) Trial: Sustained Benefit of Fibrin-Specific Therapy. Circulation. 100(18). 1 indexed citations

Califf, RM & DB Mark. (1994). Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases.. PubMed. 6(2). 120–8. 8 indexed citations

Lh, Muhlbaier, Pryor Db, Rankin Js, et al.. (1992). Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up.. PubMed. 86(5 Suppl). II198–204. 55 indexed citations

Lr, Smith, Harrell Fe, Rankin Js, et al.. (1991). Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.. PubMed. 84(5 Suppl). III245–53. 122 indexed citations

Hlatky, Mark A., RM Califf, KL Lee, et al.. (1991). Clinical Judgment and Therapeutic Decision Making. 1 indexed citations

10.

Mark, DB, et al.. (1989). Rescue Coronary Angioplasty after Failure of Intravenous Streptokinase in Acute Myocardial Infarction: In-Hospital and Long-Term Outcomes. The Journal of invasive cardiology. 1. 14 indexed citations

11.

Mark, DB, Mark A. Hlatky, Harrell Fe, et al.. (1988). Surgical survival benefits for coronary disease patients with left ventricular dysfunction.. PubMed. 78(3 Pt 2). I151–7. 105 indexed citations

12.

Califf, RM, Harrell Fe, KL Lee, et al.. (1988). Changing efficacy of coronary revascularization. Implications for patient selection.. Circulation. 78(3 Pt 2). I185–91. 22 indexed citations

13.

Db, Pryor, Harrell Fe, KL Lee, et al.. (1988). Trends in the Presentation, Management, and Survival of Patients with Coronary Artery Disease: The Duke Database for Cardiovascular Disease. 9 indexed citations

14.

Db, Pryor, Harrell Fe, Rankin Js, et al.. (1987). The changing survival benefits of coronary revascularization over time.. PubMed. 76(5 Pt 2). V13–21. 44 indexed citations

15.

Califf, RM, Mark A. Hlatky, DB Mark, et al.. (1985). Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center.. PubMed. 72(6 Pt 2). V136–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact